Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» February 2012
February 2012
ViroPharma Reports Encouraging Data
ViroPharma Reports Encouraging Data
Yahoo/Zacks.com
ViroPharma
Plenadren
adrenal insufficiency
Opportunity In The Weight Loss Drug Market
Opportunity In The Weight Loss Drug Market
Seeking Alpha
obesity
Vivus
Qnexa
Abbott Laboratories
Alkermes
GSK
JNJ
Roche
Orexigen
FDA Accepts Pfizer Drug NDA
FDA Accepts Pfizer Drug NDA
Yahoo/Zacks.com
Pfizer
FDA
tafamidis meglumine
transthyretin familial amyloid polyneuropathy
Johnson & Johnson CEO Weldon to step down in April
Johnson & Johnson CEO Weldon to step down in April
Reuters
JNJ
William Weldon
Pharma CEOs
A Negative Vote for Vivus Obesity Drug, Says 'FDA Panel Whisperer'
A Negative Vote for Vivus Obesity Drug, Says 'FDA Panel Whisperer'
TheStreet.com
obesity
Vivus
advisory panel
FDA
Qnexa
Vertex: The Best Of The Companies Investing In Cystic Fibrosis
Vertex: The Best Of The Companies Investing In Cystic Fibrosis
Seeking Alpha
cystic fibrosis
Vertex
Gilead
Novartis
Sanofi
US FDA acts to stem shortages of two cancer drugs
US FDA acts to stem shortages of two cancer drugs
Reuters
methotrexate
cancer
drug shortages
JNJ
Doxil
FDA
J&J Rejected in U.S. High Court Bid to Reinstate Abbott Verdict
J&J Rejected in U.S. High Court Bid to Reinstate Abbott Verdict
Bloomberg
JNJ
Abbott Laboratories
Humira
patents
Enanta partners with Novartis to develop new drug to treat hepatitis C virus
Enanta partners with Novartis to develop new drug to treat hepatitis C virus
Boston Globe, MA
Novartis
Enanta
hepatitis C
EDP-239
Feds Subpoena Bristol-Myers Over Abilify Marketing
Feds Subpoena Bristol-Myers Over Abilify Marketing
Pharmalot
Abilify
Bristol-Myers Squibb
Pages
« first
‹ previous
…
10
11
12
13
14
15
16
17
18
…
next ›
last »